Oncternal Therapeutics Inc (ONCT)
8.01
-0.30
(-3.61%)
USD |
NASDAQ |
May 01, 16:00
8.01
0.00 (0.00%)
After-Hours: 20:00
Oncternal Therapeutics Enterprise Value: -9.660M for April 30, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 30, 2024 | -9.660M |
| April 29, 2024 | -9.158M |
| April 26, 2024 | -9.720M |
| April 25, 2024 | -9.838M |
| April 24, 2024 | -8.965M |
| April 23, 2024 | -8.314M |
| April 22, 2024 | -8.950M |
| April 19, 2024 | -8.033M |
| April 18, 2024 | -8.802M |
| April 17, 2024 | -7.767M |
| April 16, 2024 | -8.536M |
| April 15, 2024 | -8.210M |
| April 12, 2024 | -6.435M |
| April 11, 2024 | -7.796M |
| April 10, 2024 | -8.515M |
| April 09, 2024 | -8.743M |
| April 08, 2024 | -7.619M |
| April 05, 2024 | -8.654M |
| April 04, 2024 | -8.210M |
| April 03, 2024 | -7.619M |
| April 02, 2024 | -6.820M |
| April 01, 2024 | -6.731M |
| March 28, 2024 | -7.619M |
| March 27, 2024 | -9.986M |
| March 26, 2024 | -10.42M |
| Date | Value |
|---|---|
| March 25, 2024 | -9.956M |
| March 22, 2024 | -9.927M |
| March 21, 2024 | -10.70M |
| March 20, 2024 | -9.542M |
| March 19, 2024 | -10.93M |
| March 18, 2024 | -11.17M |
| March 15, 2024 | -10.52M |
| March 14, 2024 | -11.11M |
| March 13, 2024 | -7.471M |
| March 12, 2024 | -7.619M |
| March 11, 2024 | -5.266M |
| March 08, 2024 | -5.872M |
| March 07, 2024 | -6.879M |
| March 06, 2024 | -5.991M |
| March 05, 2024 | -6.139M |
| March 04, 2024 | -4.204M |
| March 01, 2024 | -4.570M |
| February 29, 2024 | -6.730M |
| February 28, 2024 | -6.255M |
| February 27, 2024 | -5.664M |
| February 26, 2024 | -6.848M |
| February 23, 2024 | -7.499M |
| February 22, 2024 | -7.026M |
| February 21, 2024 | -7.396M |
| February 20, 2024 | -8.802M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-47.57M
Minimum
May 13 2022
352.34M
Maximum
Apr 07 2021
35.43M
Average
18.59M
Median
Oct 01 2020
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.389M |
| Palatin Technologies Inc | 20.53M |
| iBio Inc | 15.83M |
| Theriva Biologics Inc | -13.32M |
| Oragenics Inc | 3.060M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -9.164M |
| Total Expenses (Quarterly) | 9.636M |
| EPS Diluted (Quarterly) | -3.03 |
| Earnings Yield | -167.7% |